RECORD // Company
Processa Pharmaceuticals, Inc.
Formerly: Heatwurx, Inc.
Built 2026-11-22T05:05:16Z from public sources · JSON · Open the company profile
ASK THE RECORDS
Ask
COMPANY
Records for this company (2 joined by official identifier)
Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.
Gleif lei (1)
- Processa Pharmaceuticals, Inc. · legal entity in this company's GLEIF ownership tree (LEI 529900A51HZIE4XJB960)
SEC EDGAR (1)
- Processa Pharmaceuticals, Inc. · the SEC registrant record of this company
Matched by name only, not merged (2)
These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).
- Processa Pharmaceuticals · Ctgov · exact name match to 'Processa Pharmaceuticals, Inc.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
- PROCESSA PHARMACEUTICALS, INC. · East licences · same registered legal name as 'Processa Pharmaceuticals, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
2 VALUES · 10-Q · EACH LINKS TO ITS FILING
Latest quarter
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-13 · accession 0001493152-26-051827
| Item | Value | Period | Form | Filed | Accession | Report | |
|---|---|---|---|---|---|---|---|
| Net income (loss) | $-183,157,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-13 | 0001493152-26-051827 | 2026-11-22 05:05 UTC | Report an error |
| Cash and cash equivalents | $180,205,000 | at 2026-09-30 | 10-Q | 2026-11-13 | 0001493152-26-051827 | 2026-11-22 05:05 UTC | Report an error |
Negative as reported in the filing.
Not in this report's XBRL: Revenue, Interest expense.
Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.
IDS
Identifiers
- SEC CIK
- 0001533743
- Ticker
- PCSA
- EIN
- 451539785
- CUSIP
- 74275C403
- Record ID
- sx:sec:0001533743
OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA
Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
28 FACTS · EACH LINKS TO ITS FILING
Facts
| Fact | Value | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 05:05 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 05:05 UTC | Report an error |
| State of incorporation | DE | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 05:05 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 05:05 UTC | Report an error |
| Business address | 601 21ST STREET, SUITE 300, VERO BEACH, FL, 32960 | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 05:05 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 05:05 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | $-13,563,834 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | 2026-11-22 05:05 UTC | Report an error |
| Total assets (at 2025-12-31) | $7,813,567 | 2025-12-31 | 10-K, XBRL Assets | 2026-11-22 05:05 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $5,577,314 | 2025-12-31 | 10-K, XBRL StockholdersEquity | 2026-11-22 05:05 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $5,536,955 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | 2026-11-22 05:05 UTC | Report an error |
| Operating cash flow (fiscal year ended 2025-12-31) | $-11,385,195 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | 2026-11-22 05:05 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2024-12-31) | $3,244 | 2024-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | 2026-11-22 05:05 UTC | Report an error |
| Operating lease liabilities (at 2024-12-31) | $66,905 | 2024-12-31 | 10-K, XBRL OperatingLeaseLiability | 2026-11-22 05:05 UTC | Report an error |
| Form D total offering amount (D filed 2021-02-19) | $10,238,773 | 2021-02-19 | D | 2026-11-22 05:05 UTC | Report an error |
| Form D total amount sold (D filed 2021-02-19) | $10,238,773 | 2021-02-19 | D | 2026-11-22 05:05 UTC | Report an error |
| Form D industry group | Pharmaceuticals | 2021-02-19 | D | 2026-11-22 05:05 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2021-02-19 | D | 2026-11-22 05:05 UTC | Report an error |
| Form D date of first sale | 2021-02-16 | 2021-02-19 | D | 2026-11-22 05:05 UTC | Report an error |
| Largest institutional holder #1 (13F as filed): Connective Capital Management, LLC | $163,726 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:05 UTC | Report an error |
| Largest institutional holder #2 (13F as filed): Stonepine Capital Management, LLC | $105,600 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:05 UTC | Report an error |
| Largest institutional holder #3 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC | $42,412 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:05 UTC | Report an error |
| Largest institutional holder #4 (13F as filed): CITADEL ADVISORS LLC | $40,908 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:05 UTC | Report an error |
| Largest institutional holder #5 (13F as filed): StoneX Group Inc. | $29,623 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:05 UTC | Report an error |
| Largest institutional holder #6 (13F as filed): XTX Topco Ltd | $25,521 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:05 UTC | Report an error |
| Largest institutional holder #7 (13F as filed): JANE STREET GROUP, LLC | $25,466 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:05 UTC | Report an error |
| Largest institutional holder #8 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC | $24,440 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:05 UTC | Report an error |
| Largest institutional holder #9 (13F as filed): VANGUARD FIDUCIARY TRUST CO | $20,845 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:05 UTC | Report an error |
| Largest institutional holder #10 (13F as filed): UBS Group AG | $14,964 | 2026-06-30 | SEC Form 13F data sets (quarterly; holdings as filed) | 2026-11-22 05:05 UTC | Report an error |
EVERY DATED RECORD, NEWEST FIRST
Timeline
- 2026-11-13 Filing 10-Q filed
- 2026-11-05 Filing DEFA14A filed
- 2026-11-05 Filing DEFA14A filed
- 2026-11-05 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-11-04 Filing 8-K filed: Item 5.02 officer or director change; Item 8.01 other event; Item 9.01 exhibits
- 2026-10-29 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-10-23 Filing EFFECT filed
- 2026-10-22 Filing DEF 14A filed
- 2026-10-09 Filing PRE 14A filed
- 2026-10-09 Filing PRE 14A filed
- 2026-10-09 Filing S-3 filed
- 2026-10-05 Filing 8-K/A filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-08-14 Filing 10-Q filed
- 2026-08-04 Filing 8-K filed: Item 5.02 officer or director change; Item 5.07 shareholder vote; Item 9.01 exhibits
- 2026-07-29 Filing 8-K filed: Item 1.01 material agreement; Item 1.02 agreement terminated; Item 2.01 acquisition or disposition; Item 3.02 unregistered equity sale; Item 5.02 officer or director change; Item 5.03 charter or bylaw amendment; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-06-18 Filing DEF 14A filed
- 2026-05-07 Filing 10-Q filed
- 2026-04-30 Filing 10-K/A filed
- 2026-04-30 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-03-18 Filing 10-K filed
- 2026-02-19 Filing 8-K filed: Item 1.02 agreement terminated; Item 9.01 exhibits
- 2026-01-07 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2025-12-15 Filing 8-K filed: Item 3.03 rights of holders modified; Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2025-11-06 Filing 10-Q filed
- 2025-09-22 Filing S-8 filed
WHAT IS NOT HERE
Gaps
- Court records: not covered yet (expected 11-19).
- No H-1B LCA filed under EIN 451539785 in FY2026 Q3
- H-1B LCAs only (H-1B1 and E-3 excluded); one fiscal quarter (FY2026 Q3) only, earlier quarters not loaded
- No Form 5500 plan filed under sponsor EIN 451539785 for plan year 2025
- Plan year 2025 only (EFAST2 'Latest' file); earlier years not loaded
- No Form 990 found for EIN 451539785
- USAspending: no recipient whose SAM legal name and address match this SEC filer
SOURCES AND LICENSE
Sources
- SEC EDGAR: checked · 2026-11-22T05:05:16Z
- DOL OFLC LCA Disclosure Data: checked, nothing found · 2026-11-22T05:05:17Z
- DOL EBSA Form 5500 public datasets: checked, nothing found · 2026-11-22T05:05:17Z
- Propublica 990: checked, nothing found · 2026-11-22T05:05:18Z
- SEC 13F holdings: checked · 2026-11-22T05:05:18Z
- USAspending: checked, nothing found · 2026-11-22T05:05:20Z
CC BY 4.0 -- credit Seraphix Systems.
API
Use this record
Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.